Literature DB >> 29338438

Challenges in adult vaccination.

Eduardo de Gomensoro1, Giuseppe Del Giudice2, T Mark Doherty3.   

Abstract

Life-long primary prevention interventions beginning and continuing throughout an individual's lifetime are increasingly seen as key to meeting the global healthcare challenges that accompany demographic changes - a concept referred to as "Healthy aging". In this perspective, vaccination is seen as part of a triad, together with healthy diet and exercise. Current adult vaccine coverage is lower than target vaccination rates in most developed countries, and so vaccine preventable diseases continue to present a substantial burden on health and healthcare resources, especially in older individuals. In part, this is due to lack of knowledge and understanding of the benefits of vaccination, inconsistent recommendations by providers and uncertainties about cost benefits. However, lower vaccine effectiveness in older adults plays a part, and new vaccines with novel characteristics to improve effectiveness in older adults are required. A life-course immunization approach to ensure optimal vaccine uptake across adults of all ages can be expected to reduce morbidity and mortality in later life. To achieve this, greater emphasis on public and healthcare provider education is necessary, based on appropriate economic analyses that demonstrate the overall value of vaccination. This article introduces the technical, economic, political and demographic issues that make establishing effective adult vaccination programs such a difficult, but pressing issue, and outlines some of the steps that are now being taken to address them. Key messages Life-long preventive activities that start and continue throughout life are essential, especially as the world's population is "getting older". This "Healthy aging" approach includes not only healthy diet and physical exercise; vaccination is critical in reducing some infectious diseases and their complications. Many adults, especially older adults (who have lower immunity than younger people) develop infections such as influenza and shingles that could potentially be prevented through vaccination. This review provides a perspective on the challenges in delivering a life-course immunization program. While some vaccines are less effective in older people, newer vaccines have been developed which provide stronger and longer protection in older patients than standard existing vaccines. However, the benefits of vaccination can only be realized if the vaccines are recommended and used. For that purpose, greater education of patients and their healthcare providers is necessary. Better knowledge of vaccines and making sure that all adults are up to date with all their recommended vaccines is an essential part of "Healthy aging". This should prevent not only vaccine-preventable diseases but also reduce the risk of complications in later life.

Entities:  

Keywords:  Vaccine; cost; coverage; effectiveness; healthy aging; impact; older adults

Mesh:

Year:  2018        PMID: 29338438     DOI: 10.1080/07853890.2017.1417632

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  15 in total

1.  Large-Sized Graphene Oxide Nanosheets Increase DC-T-Cell Synaptic Contact and the Efficacy of DC Vaccines against SARS-CoV-2.

Authors:  Qianqian Zhou; Hongjing Gu; Sujing Sun; Yulong Zhang; Yangyang Hou; Chenyan Li; Yan Zhao; Ping Ma; Liping Lv; Subi Aji; Shihui Sun; Xiaohui Wang; Linsheng Zhan
Journal:  Adv Mater       Date:  2021-08-16       Impact factor: 32.086

2.  Increasing Influenza and Pneumococcal Vaccination Uptake in Seniors Using Point-of-Care Informational Interventions in Primary Care in Singapore: A Pragmatic, Cluster-Randomized Crossover Trial.

Authors:  Hanley J Ho; Yi-Roe Tan; Alex R Cook; Gerald Koh; Tat Yean Tham; Eve Anwar; Grace Shu Hui Chiang; May O Lwin; Mark I Chen
Journal:  Am J Public Health       Date:  2019-10-17       Impact factor: 9.308

Review 3.  Immunization: vital progress, unfinished agenda.

Authors:  Peter Piot; Heidi J Larson; Katherine L O'Brien; John N'kengasong; Edmond Ng; Samba Sow; Beate Kampmann
Journal:  Nature       Date:  2019-11-06       Impact factor: 49.962

Review 4.  Promoting Healthy Ageing in South Africa Through Vaccination of the Elderly.

Authors:  Mncengeli Sibanda; Johanna C Meyer; Kesentseng J Mahlaba; Rosemary J Burnett
Journal:  Front Public Health       Date:  2021-04-26

Review 5.  Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project.

Authors:  Debbie Van Baarle; Kaatje Bollaerts; Giuseppe Del Giudice; Stephen Lockhart; Christine Luxemburger; Maarten J Postma; Aura Timen; Baudouin Standaert
Journal:  Vaccine       Date:  2020-07-24       Impact factor: 3.641

6.  Association of Number of Doses With Hepatitis B Vaccine Series Completion in US Adults.

Authors:  Katia Bruxvoort; Jeff Slezak; Runxin Huang; Bradley Ackerson; Lina S Sy; Lei Qian; Kristi Reynolds; William Towner; Zendi Solano; Cheryl Mercado; Randall Hyer; Robert Janssen; Steven J Jacobsen
Journal:  JAMA Netw Open       Date:  2020-11-02

Review 7.  The Burden of Invasive Vaccine-Preventable Diseases in Adults in the Middle East and North Africa (MENA) Region.

Authors:  Abdul Rahman Bizri; Abdulhakeem Althaqafi; Nawal Kaabi; Nathir Obeidat; Nadine Al Akoury; Hammam Haridy
Journal:  Infect Dis Ther       Date:  2021-03-22

Review 8.  Developing Adult Vaccination Ecosystem in India: Current Perspective and the Way Forward.

Authors:  Canna Jagdish Ghia; Gautam Sudhakar Rambhad
Journal:  Health Serv Res Manag Epidemiol       Date:  2021-07-07

9.  Archetype analysis of older adult immunization decision-making and implementation in 34 countries.

Authors:  Lois Privor-Dumm; Prarthana Vasudevan; Kana Kobayashi; Jaya Gupta
Journal:  Vaccine       Date:  2020-04-16       Impact factor: 3.641

10.  COVID-19 Vaccination: Concerns About Its Accessibility, Affordability, and Acceptability.

Authors:  Inayat Ali; Shahbaz Ali; Sehar Iqbal
Journal:  Front Med (Lausanne)       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.